Grantham, Mayo, Van Otterloo & Co (GMO)’s Constellium CSTM Stock Holding History
Bought
Maintained
Sold
Other funds holding CSTM
B
VNIM
PWAM
EGA
BGIM
Grantham, Mayo, Van Otterloo & Co (GMO)'s CSTM Position: Q4 2018 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Constellium (CSTM) in Q4 2018, closing a stake of 33,500 shares — an estimated $414K sold.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CSTM in Q3 2017 and held it in 5 quarters. The position peaked at $7.25M in Q4 2017. 137 funds tracked by Wall St. Rank hold CSTM as of Q4 2018.
- Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Constellium position as of Q4 2018 after selling out during the quarter.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 33,500 Constellium shares in Q4 2018, an estimated $414K.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Constellium in Q3 2017 and held it in 5 quarters.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Constellium position peaked at $7.25M in Q4 2017.
- 137 funds tracked by Wall St. Rank held Constellium as of Q4 2018.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2018, filed 13 Feb 2019.